AU2002222287A1 - Piperazine derivatives for treatment of bacterial infections - Google Patents
Piperazine derivatives for treatment of bacterial infectionsInfo
- Publication number
- AU2002222287A1 AU2002222287A1 AU2002222287A AU2228702A AU2002222287A1 AU 2002222287 A1 AU2002222287 A1 AU 2002222287A1 AU 2002222287 A AU2002222287 A AU 2002222287A AU 2228702 A AU2228702 A AU 2228702A AU 2002222287 A1 AU2002222287 A1 AU 2002222287A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- bacterial infections
- piperazine derivatives
- derivatives
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Piperazine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0031088.8A GB0031088D0 (en) | 2000-12-20 | 2000-12-20 | Medicaments |
GB0031088.8 | 2000-12-20 | ||
PCT/GB2001/005653 WO2002050061A1 (en) | 2000-12-20 | 2001-12-19 | Piperazine derivatives for treatment of bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002222287A1 true AU2002222287A1 (en) | 2002-07-01 |
Family
ID=9905481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002222287A Abandoned AU2002222287A1 (en) | 2000-12-20 | 2001-12-19 | Piperazine derivatives for treatment of bacterial infections |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040077655A1 (en) |
EP (1) | EP1343780B1 (en) |
JP (1) | JP2004518661A (en) |
AT (1) | ATE340171T1 (en) |
AU (1) | AU2002222287A1 (en) |
DE (1) | DE60123276T2 (en) |
ES (1) | ES2269301T3 (en) |
GB (1) | GB0031088D0 (en) |
WO (1) | WO2002050061A1 (en) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL154107A0 (en) | 2000-07-26 | 2003-07-31 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
JP2004509885A (en) * | 2000-09-21 | 2004-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Quinoline derivatives as antibacterial agents |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
US6632810B2 (en) * | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
DE60234453D1 (en) * | 2001-07-02 | 2009-12-31 | High Point Pharmaceuticals Llc | SUBSTITUTED PIPERAZINE AND DIAZEPANDERIVATES FOR USE AS HISTAMINE H3 RECEPTOR MODULATORS |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
US7109213B2 (en) * | 2002-01-29 | 2006-09-19 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
TW200406410A (en) | 2002-01-29 | 2004-05-01 | Glaxo Group Ltd | Compounds |
CN1172919C (en) * | 2002-06-03 | 2004-10-27 | 上海医药工业研究院 | Alkyl alcohol piperazine derivative and its application in preparing medicine for treating depression |
AR040335A1 (en) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | CYCLLOHEXAN OR CYCLHEXENE COMPOUND, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE AND INTERMEDIATE COMPOUNDS OF UTILITY TO PREPARE SUCH COMPOUND |
AR040336A1 (en) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND |
GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
AU2003301414B8 (en) * | 2002-10-10 | 2010-06-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Novel compounds with antibacterial activity |
ATE479683T1 (en) | 2002-11-05 | 2010-09-15 | Glaxo Group Ltd | ANTIBACTERIAL AGENTS |
US7232832B2 (en) * | 2002-11-05 | 2007-06-19 | Smithkline Beecham Corporation | Antibacterial agents |
JP2006515862A (en) | 2002-12-04 | 2006-06-08 | グラクソ グループ リミテッド | Quinolines and their nitrogenated derivatives and their use as antibacterial agents |
TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
CN100471856C (en) * | 2003-07-31 | 2009-03-25 | Irm责任有限公司 | Bicyclic compounds and compostions as PDF inhibitors |
WO2006020561A2 (en) * | 2004-08-09 | 2006-02-23 | Glaxo Group Limited | Antibacterial agents |
BRPI0519288A2 (en) | 2004-12-24 | 2009-01-06 | Astrazeneca Ab | heterocyclic compounds as ccr2b antagonists |
GB0428327D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Ab | Method |
ME02929B (en) | 2004-12-30 | 2018-04-20 | Janssen Pharmaceutica Nv | 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase (faah) for the treatment of anxiety, pain and other conditions |
US7592334B2 (en) | 2005-01-25 | 2009-09-22 | Glaxo Group Limited | Antibacterial agents |
EP1846416A4 (en) | 2005-01-25 | 2009-07-01 | Glaxo Group Ltd | Antibacterial agents |
WO2006081264A1 (en) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
EP1845995A4 (en) | 2005-01-25 | 2010-03-03 | Glaxo Group Ltd | Antibacterial agents |
US7511035B2 (en) | 2005-01-25 | 2009-03-31 | Glaxo Group Limited | Antibacterial agents |
US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
JP4902247B2 (en) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | Novel production method of 2- (1-benzothiophen-5-yl) ethanol and its intermediate |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP2468743A1 (en) | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Nitrogen-containing bicyclic compounds useful as antibacterial agents |
GB0525957D0 (en) * | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
CA2635126A1 (en) | 2006-01-26 | 2007-08-02 | Actelion Pharmaceuticals Ltd | Tetrahydropyrane antibiotics |
WO2007098214A1 (en) * | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
MX2008010953A (en) * | 2006-02-28 | 2008-09-08 | Amgen Inc | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors. |
AU2007223801A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
US7709483B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
WO2007118130A2 (en) | 2006-04-06 | 2007-10-18 | Glaxo Group Limited | Antibacterial agents |
BRPI0712163A2 (en) | 2006-05-26 | 2012-03-13 | Toyama Chemical Co., Ltd. | compound and antimicrobial agent |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
BRPI0810064B8 (en) * | 2007-04-20 | 2021-05-25 | Glaxo Group Ltd | compounds containing tricyclic nitrogen as antibacterial agents, pharmaceutical compositions comprising said compounds and their use for the treatment of bacterial infections in mammals |
CN101874032B (en) | 2007-11-26 | 2013-02-06 | 富山化学工业株式会社 | Novel naphthyridine derivative monohydrate and method for producing the same |
EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
WO2010043714A1 (en) | 2008-10-17 | 2010-04-22 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
JP5653935B2 (en) | 2009-01-15 | 2015-01-14 | グラクソ グループ リミテッドGlaxo Group Limited | Naphthyridin-2 (1H) -one compounds useful as antibacterial agents |
US8673920B2 (en) | 2009-05-06 | 2014-03-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
KR20120081119A (en) * | 2009-09-04 | 2012-07-18 | 잘리커스 파마슈티컬즈 리미티드 | Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
WO2012058116A1 (en) | 2010-10-27 | 2012-05-03 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2632464B1 (en) | 2010-10-29 | 2015-04-29 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
KR20140052034A (en) | 2011-08-19 | 2014-05-02 | 머크 샤프 앤드 돔 코포레이션 | Inhibitors of the renal outer medullary potassium channel |
WO2013039802A1 (en) | 2011-09-16 | 2013-03-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2771004B1 (en) | 2011-10-25 | 2016-05-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
US8999990B2 (en) | 2011-10-25 | 2015-04-07 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2773351B1 (en) | 2011-10-31 | 2017-08-23 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
US9139585B2 (en) | 2011-10-31 | 2015-09-22 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
US9108947B2 (en) | 2011-10-31 | 2015-08-18 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
EP2790511B1 (en) | 2011-12-16 | 2016-09-14 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
AR089929A1 (en) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | PROCESS TO MANUFACTURE A NAFTIRIDINE DERIVATIVE |
AR092031A1 (en) | 2012-07-26 | 2015-03-18 | Merck Sharp & Dohme | INHIBITORS OF THE EXTERNAL RENAL MEDULAR POTASSIUM CHANNEL |
GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
US9777002B2 (en) | 2012-11-29 | 2017-10-03 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
WO2014099633A2 (en) | 2012-12-19 | 2014-06-26 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2956142B1 (en) | 2013-02-18 | 2017-09-20 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
EP2961403A4 (en) | 2013-03-01 | 2016-11-30 | Zalicus Pharmaceuticals Ltd | Heterocyclic inhibitors of the sodium channel |
EP2968288B1 (en) | 2013-03-15 | 2018-07-04 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
WO2015017305A1 (en) | 2013-07-31 | 2015-02-05 | Merck Sharp & Dohme Corp | Inhibitors of the renal outer medullary potassium channel |
EP3686200A3 (en) | 2013-12-20 | 2020-09-09 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
EP3110799A4 (en) * | 2014-02-27 | 2017-10-11 | Epirus Biopharmaceuticals, Inc. | Heterocyclic inhibitors of the sodium channel |
ES2759303T3 (en) | 2014-08-22 | 2020-05-08 | Glaxosmithkline Ip Dev Ltd | Tricyclic nitrogen-containing compounds to treat Neisseria gonorrhoeae infection |
WO2016127358A1 (en) | 2015-02-12 | 2016-08-18 | Merck Sharp & Dohme Corp. | Inhibitors of renal outer medullary potassium channel |
UY36851A (en) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS |
WO2021076886A1 (en) | 2019-10-18 | 2021-04-22 | The Regents Of The University Of California | 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR86513E (en) * | 1963-03-25 | 1966-02-25 | Rhone Poulenc Sa | New quinoline derivatives and their preparation |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
EP0541486A1 (en) * | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclic conjugates |
US6194413B1 (en) * | 1995-11-13 | 2001-02-27 | Smithkline Beecham Corporation | Hemoregulatory compounds |
WO1999037635A1 (en) * | 1998-01-26 | 1999-07-29 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9822440D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9914486D0 (en) * | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917406D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
US6403610B1 (en) * | 1999-09-17 | 2002-06-11 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
US6803369B1 (en) * | 2000-07-25 | 2004-10-12 | Smithkline Beecham Corporation | Compounds and methods for the treatment of neoplastic disease |
IL154107A0 (en) * | 2000-07-26 | 2003-07-31 | Smithkline Beecham Plc | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
JP2004509885A (en) * | 2000-09-21 | 2004-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Quinoline derivatives as antibacterial agents |
US6603005B2 (en) * | 2000-11-15 | 2003-08-05 | Aventis Pharma S.A. | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
US6602884B2 (en) * | 2001-03-13 | 2003-08-05 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
US20030203917A1 (en) * | 2001-07-25 | 2003-10-30 | Smithkline Beecham Corporation And Smithkline Beecham P.L.C. | Compounds and methods for the treatment of neoplastic disease |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
-
2000
- 2000-12-20 GB GBGB0031088.8A patent/GB0031088D0/en not_active Ceased
-
2001
- 2001-12-19 AT AT01271369T patent/ATE340171T1/en not_active IP Right Cessation
- 2001-12-19 EP EP01271369A patent/EP1343780B1/en not_active Expired - Lifetime
- 2001-12-19 DE DE60123276T patent/DE60123276T2/en not_active Expired - Fee Related
- 2001-12-19 ES ES01271369T patent/ES2269301T3/en not_active Expired - Lifetime
- 2001-12-19 WO PCT/GB2001/005653 patent/WO2002050061A1/en active IP Right Grant
- 2001-12-19 JP JP2002551557A patent/JP2004518661A/en active Pending
- 2001-12-19 AU AU2002222287A patent/AU2002222287A1/en not_active Abandoned
- 2001-12-19 US US10/450,884 patent/US20040077655A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002050061A1 (en) | 2002-06-27 |
US20040077655A1 (en) | 2004-04-22 |
GB0031088D0 (en) | 2001-01-31 |
ES2269301T3 (en) | 2007-04-01 |
EP1343780A1 (en) | 2003-09-17 |
JP2004518661A (en) | 2004-06-24 |
WO2002050061A8 (en) | 2002-07-25 |
EP1343780B1 (en) | 2006-09-20 |
DE60123276D1 (en) | 2006-11-02 |
DE60123276T2 (en) | 2007-09-27 |
ATE340171T1 (en) | 2006-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002222287A1 (en) | Piperazine derivatives for treatment of bacterial infections | |
AU6825300A (en) | Compounds | |
GB0101577D0 (en) | Compounds | |
AU2002328972A1 (en) | Piperidine derivatives as antibacterial agents | |
GB0112836D0 (en) | Medicaments | |
AU2002218192A1 (en) | Quinoline derivatives as antibacterials | |
AU5986200A (en) | Compounds | |
GB9822440D0 (en) | Medicaments | |
GB9822450D0 (en) | Medicaments | |
MXPA03000708A (en) | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity. | |
GB0217294D0 (en) | Medicaments | |
AU2003291227A1 (en) | Antibacterial agents | |
GB0031086D0 (en) | Medicaments | |
WO2003064431A3 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
MXPA03010790A (en) | Nitrogen-containing bicyclic heterocycles for use as antibacterials. | |
EP1560821B8 (en) | Antibacterial agents | |
WO2001082788A3 (en) | Compounds and methods for the treatment and prevention of bacterial infection | |
AU2003294565A1 (en) | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | |
AU2525201A (en) | Combination of cyamemazine and an atypical neuroleptic |